S
GSK icon

Surevest’s GSK GSK Stock Holding History

Surevest’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$12K Hold
424
– – ﹤0.01% 276
2022
Q2 		$23K Buy
424
+1
+0.2% +$55 0.01% 250
2022
Q1 		$23K Buy
423
+1
+0.2% +$54 0.01% 230
2021
Q4 		$23K Buy
+422
New +$22K 0.01% 238
2020
Q2 		– Sell
-5,589
Closed -$265K – 90
2020
Q1 		$265K Sell
5,589
-399
-7% -$21.3K 0.14% 87
2019
Q4 		$352K Buy
5,988
+14
+0.2% +$779 0.15% 113
2019
Q3 		$319K Buy
5,974
+14
+0.2% +$720 0.16% 109
2019
Q2 		$298K Buy
5,960
+1,742
+41% +$87.4K 0.15% 114
2019
Q1 		$220K Sell
4,218
-691
-14% -$34.5K 0.14% 115
2018
Q4 		$234K Buy
+4,909
New +$242K 0.18% 120

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Surevest's GSK Position: Q3 2022 in Review

Surevest held its GSK (GSK) position steady in Q3 2022 at 424 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #276.

Surevest first reported a position in GSK in Q4 2018 and has held it in 10 quarters since. The position peaked at $352K in Q4 2019. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Surevest held 424 shares of GSK worth $12K as of Q3 2022.
  • Surevest left its GSK share count unchanged in Q3 2022.
  • GSK made up ﹤0.01% of Surevest's portfolio in Q3 2022, its #276 holding.
  • Surevest first reported a position in GSK in Q4 2018 and has held it in 10 quarters since.
  • Surevest's GSK position peaked at $352K in Q4 2019.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.